Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDZ domain-containing protein 7 (PDZD7) is a scaffold/adaptor protein containing three PDZ domains and a helical domain (HHD), which is crucial for its membrane targeting and lipid-binding activities[1][2]. PDZD7 is predominantly expressed in cochlear hair cells, where it organizes the ankle-link complex by interacting with other Usher syndrome type II (USH2) proteins such as Whirlin, USH2A, and VLGR1. PDZD7 is essential for the proper assembly of the ankle-link complex and the formation and development of stereocilia in inner ear hair cells, with knockout or mutation resulting in disrupted localization of these USH2 protein complexes and leading to autosomal recessive non-syndromic hearing loss (DFNB57)[1][2]. PDZD7 acts primarily as a structural scaffolding protein rather than a classical druggable target (e.g., receptor, enzyme, transporter), and no drugs are reported that directly interact with it[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDZ domain-containing protein 7 (PDZD7).